Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M59,195Revenue (TTM) $M11,449Net Margin (%)32.3Altman Z-Score5.8
Enterprise Value $M60,805EPS (TTM) $16.9Operating Margin %45.0Piotroski F-Score5
P/E(ttm)16.2Beneish M-Score-2.5Pre-tax Margin (%)43.1Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %24.8Quick Ratio2.3Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %28.9Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow15.8y-y EBITDA Growth Rate %13.6ROA % (ttm)17.4Higher Current Ratio y-yN
Dividend Yield %--PEG0.6ROE % (ttm)33.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M216ROIC % (ttm)28.4Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BIIB is held by these investors:



BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Clancy Paul JExecutive VP and CFO 2017-03-13Sell9,891$291.55-5.92view
Sandrock AlfredEVP CMO Neuro & Neurodegenerat 2017-03-01Sell973$290.07-5.44view
Vounatsos MichelCEO 2017-02-27Buy1,333$285.39-3.89view
PANGIA ROBERT WDirector 2017-01-09Sell5,450$295.39-7.14view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-12-01Sell48$296.53-7.5view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-04Sell262$311.94-12.07view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-03Sell380$313-12.36view
DORSA CAROLINEDirector 2016-09-22Sell27,570$314-12.64view
SCANGOS GEORGE ACEO 2016-07-21Sell157$280-2.04view
Koppel AdamEVP, Strategy and Bus. Dev. 2016-06-06Sell555$290-5.41view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Five Stocks I Like on the NASDAQ Market Mar 21 2017 
Jeff Auxier Invests in Gilead, Wells Fargo, Apple Mar 06 2017 
Weekly CEO Buys Highlights Mar 06 2017 
New Features: Individual Portfolio Tracker and Value Screens Tracker Mar 03 2017 
GuruFocus Interview: Orbimed Guru Sam Isaly on Investing in New Era of Healthcare Feb 15 2017 
8 Stocks Trading Below Peter Lynch Value Jan 23 2017 
7 Stocks for 2017 Jan 20 2017 
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
John Paulson Continues to Buy These 8 Stocks Dec 23 2016 
Health Care Companies Showing Good Defensive Potential Dec 22 2016 

More From Other Websites
Biogen to Present Data at the 13th International Conference on Alzheimer’s and Parkinson’s... Mar 28 2017
Biogen to Present Data at the 13th International Conference on Alzheimer’s and Parkinson’s... Mar 28 2017
Biogen to Report First Quarter 2017 Financial Results on April 25, 2017 Mar 27 2017
Cytokinetics SMA Drug Did Well in Early Study Mar 22 2017
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results Mar 22 2017
A Look at Ionis Pharmaceuticals’ Spinraza Mar 22 2017
[$$] Two Cheers for Biogen’s Court Victory Mar 21 2017
Biogen Wins Tecfidera Patent Case Mar 21 2017
Biogen Stock Pops After Judge Upholds Critical Drug Patent Mar 21 2017
Biogen wins patent decision Mar 21 2017
Biogen: Did Someone Say Biotech Stocks are Falling? Mar 21 2017
[$$] Two Cheers for Biogen's Court Victory Mar 21 2017
Biogen wins ruling in Tecfidera IP case; shares rise Mar 21 2017
Biogen prevails in dispute over key Tecfidera patent Mar 21 2017
3 Biotech Stocks That Are Broker Favorites Mar 21 2017
Biogen, Inc. breached its 50 day moving average in a Bearish Manner : BIIB-US : March 21, 2017 Mar 21 2017
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details Mar 20 2017
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade Mar 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)